tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XENE Stock Latest News

Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025
Company AnnouncementsXenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025
7d ago
XENE
Xenon’s Growth Potential and Stability: A Buy Rating Supported by Financial Strength and Strategic Initiatives
PremiumRatings
Xenon’s Growth Potential and Stability: A Buy Rating Supported by Financial Strength and Strategic Initiatives
25d ago
XENE
Xenon Pharmaceuticals to Present at Stifel 2025 Virtual CNS Forum
PremiumCompany Announcements
Xenon Pharmaceuticals to Present at Stifel 2025 Virtual CNS Forum
30d ago
XENE
Promising Pipeline and Financial Stability Justify Buy Rating for Xenon
PremiumRatings
Promising Pipeline and Financial Stability Justify Buy Rating for Xenon
1M ago
XENE
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Challenges
1M ago
XENE
Strategic Growth Potential and Upcoming Catalysts Drive Buy Rating for Xenon Pharmaceuticals
PremiumRatingsStrategic Growth Potential and Upcoming Catalysts Drive Buy Rating for Xenon Pharmaceuticals
1M ago
XENE
Xenon Pharmaceuticals price target lowered to $42 from $43 at Wedbush
Premium
The Fly
Xenon Pharmaceuticals price target lowered to $42 from $43 at Wedbush
1M ago
XENE
Xenon Pharmaceuticals price target raised to $58 from $56 at RBC Capital
Premium
The Fly
Xenon Pharmaceuticals price target raised to $58 from $56 at RBC Capital
1M ago
XENE
Promising Prospects for Xenon: Buy Rating Backed by Azetukalner’s Versatility and Strong Clinical Data
PremiumRatings
Promising Prospects for Xenon: Buy Rating Backed by Azetukalner’s Versatility and Strong Clinical Data
1M ago
XENE
Xenon’s Strategic Advancements and Promising Pipeline Drive Buy Rating
PremiumRatings
Xenon’s Strategic Advancements and Promising Pipeline Drive Buy Rating
1M ago
XENE
Xenon Pharmaceuticals Advances Clinical Pipeline Amid Financial Losses
PremiumCompany Announcements
Xenon Pharmaceuticals Advances Clinical Pipeline Amid Financial Losses
1M ago
XENE
Xenon CFO Resignation Amidst Strong Financial Outlook
PremiumCompany Announcements
Xenon CFO Resignation Amidst Strong Financial Outlook
1M ago
8K
XENE
Xenon Pharmaceuticals reports Q4 EPS (84c), consensus (84c)
PremiumThe FlyXenon Pharmaceuticals reports Q4 EPS (84c), consensus (84c)
1M ago
XENE
Xenon Pharmaceuticals to Present at TD Cowen Healthcare Conference
Premium
Company Announcements
Xenon Pharmaceuticals to Present at TD Cowen Healthcare Conference
1M ago
XENE
Xenon Pharmaceuticals (XENE) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Xenon Pharmaceuticals (XENE) Q4 Earnings Cheat Sheet
2M ago
XENE
Xenon’s Strategic Pipeline Expansion and R&D Investments Drive Buy Rating Amid Neurology Sector Opportunities
PremiumRatings
Xenon’s Strategic Pipeline Expansion and R&D Investments Drive Buy Rating Amid Neurology Sector Opportunities
2M ago
XENE
Xenon Pharmaceuticals to Announce Q4 and Full Year 2024 Financial Results
PremiumCompany Announcements
Xenon Pharmaceuticals to Announce Q4 and Full Year 2024 Financial Results
2M ago
XENE
Xenon Pharmaceuticals initiated with a Buy at Deutsche Bank
PremiumThe Fly
Xenon Pharmaceuticals initiated with a Buy at Deutsche Bank
2M ago
XENE
Positive Long-Term Outlook for Xenon Pharmaceuticals Amid Anticipated Epilepsy Data Event
PremiumRatings
Positive Long-Term Outlook for Xenon Pharmaceuticals Amid Anticipated Epilepsy Data Event
2M ago
XENE
Xenon Pharmaceuticals’ CCO Departure and Consultancy Role
PremiumCompany AnnouncementsXenon Pharmaceuticals’ CCO Departure and Consultancy Role
3M ago
8K
XENE
Xenon Pharmaceuticals Sets Sights on Key 2025 Milestones
Premium
Company Announcements
Xenon Pharmaceuticals Sets Sights on Key 2025 Milestones
3M ago
XENE
Xenon Pharmaceuticals outlines key corporate milestone opportunities for 2025
Premium
The Fly
Xenon Pharmaceuticals outlines key corporate milestone opportunities for 2025
3M ago
XENE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >